DK1051155T3 - Nasale opløsninger - Google Patents

Nasale opløsninger

Info

Publication number
DK1051155T3
DK1051155T3 DK99904823T DK99904823T DK1051155T3 DK 1051155 T3 DK1051155 T3 DK 1051155T3 DK 99904823 T DK99904823 T DK 99904823T DK 99904823 T DK99904823 T DK 99904823T DK 1051155 T3 DK1051155 T3 DK 1051155T3
Authority
DK
Denmark
Prior art keywords
nasal solutions
liquid
nasal
inter alia
relates
Prior art date
Application number
DK99904823T
Other languages
English (en)
Inventor
Christopher Buckley
Matthias Seidel
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Application granted granted Critical
Publication of DK1051155T3 publication Critical patent/DK1051155T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK99904823T 1998-01-30 1999-01-28 Nasale opløsninger DK1051155T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810069 1998-01-30
PCT/EP1999/000555 WO1999038492A1 (en) 1998-01-30 1999-01-28 Nasal solutions

Publications (1)

Publication Number Publication Date
DK1051155T3 true DK1051155T3 (da) 2002-09-16

Family

ID=8235913

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99904823T DK1051155T3 (da) 1998-01-30 1999-01-28 Nasale opløsninger

Country Status (12)

Country Link
EP (1) EP1051155B1 (da)
JP (1) JP4603687B2 (da)
AT (1) ATE219657T1 (da)
AU (1) AU741364B2 (da)
CA (1) CA2311530C (da)
DE (1) DE69901936T2 (da)
DK (1) DK1051155T3 (da)
ES (1) ES2180274T3 (da)
IL (1) IL136591A (da)
NZ (1) NZ505919A (da)
PT (1) PT1051155E (da)
WO (1) WO1999038492A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
CZ295595B6 (cs) * 1999-06-22 2005-08-17 Boehringer Ingelheim International Gmbh Stálý roztok xylometazolinu a oxymetazolinu
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
BG65734B1 (bg) * 2002-02-22 2009-09-30 Био Терапютикс - Еоод Течен мукоадхезивен фармацевтичен състав
NZ537186A (en) * 2002-06-20 2006-10-27 Novartis Consumer Health S Nasal compositions comprising a mucopolysaccharide and propylene glycol
AU2003272517A1 (en) * 2002-09-13 2004-04-30 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
CA2530531A1 (en) * 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
JP4956981B2 (ja) * 2005-01-05 2012-06-20 大正製薬株式会社 オキシメタゾリン含有水性組成物
GB2423711B (en) 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US8940796B2 (en) * 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
DE102008007198A1 (de) * 2008-02-01 2009-08-13 Infectopharm Arzneimittel Und Consilium Gmbh Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
CA2739353A1 (en) * 2008-10-10 2010-04-15 Schering Corporation Corticosteroid compositions and methods of treatments thereof
PL2759290T3 (pl) 2013-01-24 2020-03-31 Merz Pharma Gmbh & Co. Kgaa Płynny preparat w aerozolu do stosowania donosowego z wydłużonym miejscowym czasem działania
DE102013001151A1 (de) 2013-01-24 2014-07-24 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
DE202013000748U1 (de) 2013-01-24 2013-02-19 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
EP2978407B1 (en) * 2013-03-29 2020-05-06 Santa Farma Ilaç Sanayi A.S. Aqueous solution composition containing ipratropium and oxymetazoline
US20160120990A1 (en) * 2013-07-17 2016-05-05 Dow Global Technologies Llc Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose
CN105517537B (zh) 2013-09-25 2018-04-17 陶氏环球技术有限责任公司 包含纤维素醚的施加到粘膜的组合物
EP3236933B1 (en) * 2014-12-24 2018-11-14 JADRAN - GALENSKI LABORATORIJ d.d. A nasal composition containing sea water as stability-improving excipient
EP3612173B1 (en) * 2017-04-17 2023-10-11 Hikma Pharmaceuticals USA Inc. Epinephrine spray formulations
CA3102815A1 (en) * 2018-06-13 2019-12-19 Hikma Pharmaceuticals Usa Inc. Epinephrine spray formulations
LT3820439T (lt) 2018-09-11 2022-01-10 Lead Biotherapeutics Ltd. Mukoadhezinė dispersinė nanodalelių sistema ir jos gamybos būdas

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH04327533A (ja) * 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
DE69222295T2 (de) * 1992-05-26 1998-04-09 The Procter & Gamble Co., Cincinnati, Ohio Pulverförmige pharmazeutische Zusammensetzung
CA2101126A1 (en) * 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
DE69434304T2 (de) * 1993-03-26 2005-12-29 Merkus, Franciscus Wilhelmus H.M. Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin
JPH07109228A (ja) * 1993-10-08 1995-04-25 Earth Chem Corp Ltd リゾチーム配合口腔用組成物
ATE249234T1 (de) * 1993-12-17 2003-09-15 Mochida Pharm Co Ltd Lösliches thrombomodulin enthaltende zubereitung
JP3269770B2 (ja) * 1995-03-02 2002-04-02 参天製薬株式会社 再分散性の優れたイオン性高分子配合水性懸濁点眼剤
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
WO1999016471A1 (en) * 1997-10-01 1999-04-08 Wakamoto Pharmaceutical Co., Ltd. O/w emulsion compositions

Also Published As

Publication number Publication date
DE69901936D1 (de) 2002-08-01
CA2311530A1 (en) 1999-08-05
EP1051155A1 (en) 2000-11-15
AU741364B2 (en) 2001-11-29
WO1999038492A1 (en) 1999-08-05
ES2180274T3 (es) 2003-02-01
EP1051155B1 (en) 2002-06-26
PT1051155E (pt) 2002-10-31
IL136591A (en) 2005-08-31
DE69901936T2 (de) 2002-11-28
ATE219657T1 (de) 2002-07-15
CA2311530C (en) 2008-06-10
JP2002501884A (ja) 2002-01-22
AU2519899A (en) 1999-08-16
NZ505919A (en) 2002-10-25
IL136591A0 (en) 2001-06-14
JP4603687B2 (ja) 2010-12-22

Similar Documents

Publication Publication Date Title
ATE219657T1 (de) Nasale lösungen
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR9902086A (pt) Formulações farmacêuticas.
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
DK0812198T3 (da) Stabilisering af prostaglandinpræparater
SE0001899D0 (sv) New compounds
DE60108236D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
HUP0101498A1 (hu) Dexmedetomidin alkalmazása nyugtató hatású gyógyszerkészítmények előállítására
BR0114912A (pt) Kahalalide f
SE9801494D0 (sv) Novel use
PT1105114E (pt) Composicoes farmaceuticas topicas contendo nimesulide
DE69911388D1 (de) Orale antimikrobielle und desodoriende zusammensetzungen
DK1092431T3 (da) Lasofoxifenpræparater
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DK0977871T3 (da) Neurotrypsin
MY136633A (en) Stabilized brivudine topical formulations
ATE241640T1 (de) Fusidinsäure-derivate
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
MXPA03010821A (es) Composiciones de aroma y fragancias.
TR200001466T2 (tr) Burun solüsyonları